GSTA7P

Across TCGA pan-cancer cohorts, GSTA7P RNA is linked to patient survival in 18 of 34 cancer types, making it the most broadly survival-associated GSTA7P data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher GSTA7P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated GSTA7P expression acts as an unfavorable survival marker, although some lineages such as LUSC and KIRC show a favorable association.

STAD, KICH, and LUSC are the cancer types where GSTA7P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	DFS	Median	All	0.574	0.700	.002	99	view →
KICH	DFS	Tertile	III,IV	0.025	0.773	<.001	81	view →
LUSC	DFS	Median	All	0.810	0.702	.001	76	view →
KIRP	DFS	Quartile	All	0.466	0.663	<.001	48	view →
KIRC	DFS	Quartile	II,III,IV	0.610	0.377	.002	45	view →
COAD	OS	Tertile	III,IV	0.140	0.694	.001	45	view →
READ	DFS	Tertile	III,IV	0.372	0.771	.005	39	view →
ESCA	OS	Tertile	IV	0.095	0.512	.008	36	view →
OV	OS	Tertile	All	0.440	0.306	.020	36	view →
PAAD	OS	Quartile	All	0.247	0.552	.007	33	view →
CHOL	OS	Quartile	II,III,IV	0.144	0.825	<.001	18	view →
SARC	OS	Tertile	All	0.937	0.799	.003	18	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 18 lineages.

GSTA7P–STAD (DFS)

Open the STAD breakdown →